Among pathways most significantly enriched for proteins with elevated abundance in higher PD-L1 expressing NSCLC are Myc targets (variant 1) (Fig. 3C), Myc targets (variant 2), G2M checkpoint and E2F targets. The gene discussed is CD274; the disease is non-small cell lung carcinoma.